メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
岩田 卓
産婦人科学(婦人科)
ウェブサイト
https://k-ris.keio.ac.jp/html/100005266_ja.html
h-index
2030
被引用数
26
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2000
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(99)
類似のプロファイル
(6)
フィンガープリント
Takashi Iwataが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Cervical Cancer
100%
Wart Virus
60%
Cervical Intraepithelial Neoplasia
43%
Endometrial Cancer
36%
Neoplasm
30%
Human Papillomavirus Type 16
27%
Prognostic Factor
23%
Cervicectomy
23%
Uterine Cervix
23%
Immunotherapy
19%
Malignant Neoplasm
17%
Cancer Testis Antigen
17%
Prevalence
17%
Adenocarcinoma
15%
Gynecological Oncology
14%
Microsatellite Instability
14%
Immune Checkpoint Inhibitor
13%
Radiation Therapy
13%
Colposcopy
13%
Wart Virus Vaccine
13%
Cervical Cancer Screening
12%
Overall Survival
12%
Neuroendocrine Carcinoma
11%
Cell Therapy
11%
Biological Marker
10%
Squamous Cell Carcinoma
10%
Clinical Trial
10%
Recurrent Disease
10%
Adenocarcinoma in Situ
10%
Lymph Duct
10%
Tumor Infiltrating Lymphocyte
9%
Carcinogenesis
9%
Papillomavirus Infection
9%
Ovarian Cancer
9%
Chemoradiotherapy
9%
Clinical Stage
9%
Retrospective Study
8%
Cervix
8%
Nodular Melanoma
8%
Lymphocytic Infiltration
8%
Radical Hysterectomy
8%
Metastatic Carcinoma
7%
Lymph Node Metastasis
7%
Adjuvant Therapy
7%
Gene Mutation
7%
Liquid-Based Cytology
7%
Cross Sectional Study
7%
Immune Response
7%
Disease Free Survival
7%
Human Papillomavirus Type 52
6%
Immunology and Microbiology
Wart Virus
51%
Human Papillomavirus Type 16
42%
Cancer Cell
27%
T Cell
23%
Human Papillomavirus Type 18
20%
Tumor-Infiltrating Lymphocytes
16%
Mouse
15%
Immune Response
14%
Promoter Region
13%
Transcription Factors
12%
Virus Genome
11%
Cancer Testis Antigen
11%
Immunosuppression
11%
Homeobox
11%
Cancer Tissue
10%
Immunosuppressive Drug
10%
CD8
9%
Prevalence
8%
Human Papillomavirus Type 58
8%
Cytotoxic T-Cell
8%
Immune Checkpoint Blockade
8%
Gene Expression
7%
Cervarix
7%
CD4
7%
Human Papillomavirus Type 31
7%
Human Papillomavirus Type 52
7%
Immunotherapy
6%
Chimeric Antigen Receptor T-Cell
6%
Catenin
6%
Programmed Death 1 Receptor
6%
Drug Megadose
6%
Molecular Epidemiology
5%
Vaccine Efficacy
5%
Renin Angiotensin Aldosterone System
5%
Mutagenesis
5%
Endoplasmic Reticulum Stress
5%
Peripheral Blood Mononuclear Cell
5%
Oncogene
5%
Nucleosome
5%
Microsatellite Instability
5%
Repair Enzyme
5%
Lymphocyte
5%
Cell Stress
5%
Cell Infiltration
5%
MHC Class I
5%
Uterine Cervix Mucosa
5%
Cell Culture
5%
CD86
5%
Phylogeny
5%
Keyphrases
Cancer-testis Antigen
11%
Endometrial Cancer
11%
T Cells
9%
Immune Response
7%
Cancer Cells
7%
Cervical Carcinoma
7%
High-risk Human Papillomavirus (HR-HPV)
6%
In Cancer
6%
Microsatellite Instability-high (MSI-H)
6%
Immune Checkpoint Therapy
5%
P16INK4a Immunohistochemistry
5%
Low-grade Squamous Intraepithelial Lesion
5%
Multicenter Retrospective Study
5%
P16INK4a/Ki-67
5%
L1 Gene
5%
Herd Effect
5%
Specimen Collection
5%
Esophageal Squamous Cell Cancer
5%
Papanicolaou Test
5%
Peritoneal Inclusion Cyst
5%
9-valent
5%
Prognostic Factors
5%
Vesicouterine Ligament
5%
Epigenetic Inactivation
5%
NOG Mice
5%
Metastatic Cervical Cancer
5%
Stearoyl-CoA Desaturase 1 (SCD1)
5%
Nucleosome Positioning
5%
Graft-versus-host Disease (GvHD)
5%
APOBEC Signature
5%
Colposcopy
5%
Within-host
5%
Digital Colposcopy
5%
High-grade Neuroendocrine Carcinoma
5%
Human Immune System
5%
UGT2B17
5%
Feminine Identity
5%
Fertility Preservation Surgery
5%
Malignant Peritoneal Cytology
5%
Japanese Patients
5%
Peripheral Blood Mononuclear Cells
5%
Abdominal Radical Trachelectomy
5%
Neuroendocrine Carcinoma
5%
Cell Analyzer
5%
Myosin 1b
5%
High-grade Lesion
5%
Long-term Evaluation
5%
Obstetric Outcomes
5%
Pembrolizumab
5%
Chemotherapy
5%
